BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7623729)

  • 1. Childhood acute lymphoblastic leukemia in India: an approach to management in a three-tier society.
    Chandy M
    Med Pediatr Oncol; 1995 Sep; 25(3):197-203. PubMed ID: 7623729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival outcome of childhood acute lymphoblastic leukemia in India: a resource-limited perspective of more than 40 years.
    Kulkarni KP; Arora RS; Marwaha RK
    J Pediatr Hematol Oncol; 2011 Aug; 33(6):475-9. PubMed ID: 21792045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating leukemia in a resource poor setting.
    Menon J; Mathews L; Purushothaman KK
    Indian Pediatr; 2008 May; 45(5):410-2. PubMed ID: 18515933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving outcome of acute lymphoblastic leukemia with a simplified protocol: report from a tertiary care center in north India.
    Trehan A; Bansal D; Varma N; Vora A
    Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27762058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period [corrected].
    Magrath I; Shanta V; Advani S; Adde M; Arya LS; Banavali S; Bhargava M; Bhatia K; Gutiérrez M; Liewehr D; Pai S; Sagar TG; Venzon D; Raina V
    Eur J Cancer; 2005 Jul; 41(11):1570-83. PubMed ID: 16026693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.
    Uderzo C; Dini G; Locatelli F; Miniero R; Tamaro P
    Haematologica; 2000 Nov; 85(11 Suppl):47-53. PubMed ID: 11268324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
    Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
    Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival outcome in childhood acute lymphoblastic leukemia in India.
    Yadav SP; Kalra M; Anjan M; Sachdeva A
    Pediatr Blood Cancer; 2010 Jan; 54(1):178; author reply 179. PubMed ID: 19731333
    [No Abstract]   [Full Text] [Related]  

  • 9. Cost of childhood acute lymphoblastic leukemia care in Shanghai, China.
    Liu Y; Chen J; Tang J; Ni S; Xue H; Pan C
    Pediatr Blood Cancer; 2009 Oct; 53(4):557-62. PubMed ID: 19526524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of socioeconomic status on childhood acute lymphoblastic leukemia treatment in Indonesia.
    Mostert S; Sitaresmi MN; Gundy CM; Sutaryo ; Veerman AJ
    Pediatrics; 2006 Dec; 118(6):e1600-6. PubMed ID: 17074838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, predictors, causes of treatment refusal and abandonment in children with acute lymphoblastic leukaemia over 18 years in North India. Treatment phase affecting factors: A step towards better focussed counselling.
    Alam A; Kumar A
    Cancer Epidemiol; 2018 Dec; 57():53-59. PubMed ID: 30316108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
    Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
    J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of children with acute lymphoblastic leukemia in India using a BFM protocol.
    Bajel A; George B; Mathews V; Viswabandya A; Kavitha ML; Srivastava A; Chandy M
    Pediatr Blood Cancer; 2008 Nov; 51(5):621-5. PubMed ID: 18688848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic strategies for childhood high-risk acute lymphoblastic leukemia].
    Lu XT
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):327-32. PubMed ID: 23591360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of a pediatric oncology program and outcomes of childhood acute lymphoblastic leukemia in a resource-poor area.
    Howard SC; Pedrosa M; Lins M; Pedrosa A; Pui CH; Ribeiro RC; Pedrosa F
    JAMA; 2004 May; 291(20):2471-5. PubMed ID: 15161898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of the risk-stratified treatment of childhood acute lymphoblastic leukemia in China.
    Shen S; Cai J; Chen J; Xue H; Pan C; Gao Y; Tang Y; Wang J; Li B; Wang X; Chen J; Gu L; Tang J
    Hematol Oncol; 2018 Oct; 36(4):679-688. PubMed ID: 30133806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nutritional and socio-economic status in the prognosis of childhood acute lymphoblastic leukemia.
    Viana MB; Fernandes RA; de Oliveira BM; Murao M; de Andrade Paes C; Duarte AA
    Haematologica; 2001 Feb; 86(2):113-20. PubMed ID: 11224478
    [No Abstract]   [Full Text] [Related]  

  • 18. Toxicity, supportive care and costs of two chemotherapy protocols for treatment of childhood ALL in Russia: BFM 90m and MB 91.
    von Stackelberg A; Karatchunsky A; Kudrjashova J; Miakova N; Belikova L; Rumiantzev A; Hartmann R; Henze G
    Eur J Cancer; 1999 Sep; 35(9):1349-55. PubMed ID: 10658526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvements in outcome of childhood acute lymphoblastic leukaemia (ALL) in the UK - a success story of modern medicine through successive UKALL trials and international collaboration.
    Bartram J; Veys P; Vora A
    Br J Haematol; 2020 Nov; 191(4):562-567. PubMed ID: 33190256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cure rates of childhood acute lymphoblastic leukemia in Lithuania and the benefit of joining international treatment protocol.
    Vaitkevičienė G; Matuzevičienė R; Stoškus M; Žvirblis T; Ragelienė L; Schmiegelow K
    Medicina (Kaunas); 2014; 50(1):28-36. PubMed ID: 25060202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.